Post by IXICO

Good to see new and familiar faces at CTAD 2025. Great energy, enthusiasm and innovation from the Alzheimer’s research community, bringing new diagnosis, treatment and care approaches to patients. Thank you to everyone who stopped by our poster explaining the use of PET imaging in AD clinical trials. Thank you also to Fortrea for co-hosting a fun and informative drinks reception discussing the challenges and opportunities of using blood-based biomarkers together with imaging in global AD studies.